These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26225723)

  • 1. The Impact of HCV Infection Duration on HIV Disease Progression and Response to cART amongst HIV Seroconverters in the UK.
    Inshaw J; Leen C; Fisher M; Gilson R; Hawkins D; Collins S; Fox J; McLean K; Fidler S; Phillips A; Lattimore S; Babiker A; Porter K;
    PLoS One; 2015; 10(7):e0132772. PubMed ID: 26225723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of tuberculosis following HIV seroconversion in high-income countries.
    Lodi S; del Amo J; d'Arminio Monforte A; Abgrall S; Sabin C; Morrison C; Furrer H; Muga R; Porter K; Girardi E;
    Thorax; 2013 Mar; 68(3):207-13. PubMed ID: 23117980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in HIV RNA and CD4 cell count after acute HCV infection in chronically HIV-infected individuals.
    Gras L; de Wolf F; Smit C; Prins M; van der Meer JT; Vanhommerig JW; Zwinderman AH; Schinkel J; Geskus RB;
    J Acquir Immune Defic Syndr; 2015 Apr; 68(5):536-42. PubMed ID: 25559595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi sarcoma incidence and survival among HIV-infected homosexual men after HIV seroconversion.
    Lodi S; Guiguet M; Costagliola D; Fisher M; de Luca A; Porter K;
    J Natl Cancer Inst; 2010 Jun; 102(11):784-92. PubMed ID: 20442214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does hepatitis C virus co-infection accelerate clinical and immunological evolution of HIV-infected patients?
    Piroth L; Duong M; Quantin C; Abrahamowicz M; Michardiere R; Aho LS; Grappin M; Buisson M; Waldner A; Portier H; Chavanet P
    AIDS; 1998 Mar; 12(4):381-8. PubMed ID: 9520167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
    van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
    Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of HIV infection duration and CD4 cell level at initiation of combination anti-retroviral therapy on risk of failure.
    Lodi S; Phillips A; Fidler S; Hawkins D; Gilson R; McLean K; Fisher M; Post F; Johnson AM; Walker-Nthenda L; Dunn D; Porter K;
    PLoS One; 2013; 8(9):e75608. PubMed ID: 24086588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration. Multicenter AIDS Cohort Study Investigators.
    Detels R; Muñoz A; McFarlane G; Kingsley LA; Margolick JB; Giorgi J; Schrager LK; Phair JP
    JAMA; 1998 Nov; 280(17):1497-503. PubMed ID: 9809730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C and progression of HIV disease.
    Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
    JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study.
    Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL
    Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.
    Haydon GH; Flegg PJ; Blair CS; Brettle RP; Burns SM; Hayes PC
    Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):485-9. PubMed ID: 9855064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of HBV and HCV coinfection on CD4 cells among HIV-infected patients: a longitudinal retrospective study.
    Silva CMD; Peder LD; Silva ES; Previdelli I; Pereira OCN; Teixeira JJV; Bertolini DA
    J Infect Dev Ctries; 2018 Nov; 12(11):1009-1018. PubMed ID: 32012132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How soon after HIV seroconversion is antiretroviral therapy initiated? The UK Register of HIV Seroconverters Steering Committee.
    AIDS; 1999 Jul; 13(10):1241-7. PubMed ID: 10416529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
    Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
    J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis progression and clinical outcomes are intertwined: role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCV-coinfected patients with detectable HCV-RNA: A MASTER cohort study.
    Focà E; Fabbiani M; Prosperi M; Quiros Roldan E; Castelli F; Maggiolo F; Di Filippo E; Di Giambenedetto S; Gagliardini R; Saracino A; Di Pietro M; Gori A; Sighinolfi L; Pan A; Postorino MC; Torti C;
    Medicine (Baltimore); 2016 Jul; 95(29):e4091. PubMed ID: 27442636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) among human immunodeficiency virus (HIV)-infected patients in an HBV endemic area in Brazil.
    da Silva CM; de Peder LD; Guelere AM; Horvath JD; Silva ES; Teixeira JJV; Bertolini DA
    PLoS One; 2018; 13(9):e0203272. PubMed ID: 30192795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HCV coinfection associated with slower disease progression in HIV-infected former plasma donors naïve to ART.
    Zhang X; Xu J; Peng H; Ma Y; Han L; Ruan Y; Su B; Wang N; Shao Y
    PLoS One; 2008; 3(12):e3992. PubMed ID: 19098990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity in HIV-1-infected individuals before and after the introduction of antiretroviral therapy: a longitudinal study of a population-based cohort in Uganda.
    Iwuji CC; Mayanja BN; Weiss HA; Atuhumuza E; Hughes P; Maher D; Grosskurth H
    HIV Med; 2011 Oct; 12(9):553-61. PubMed ID: 21535347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
    De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
    Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.